GCM Grosvenor Inc.
GCMG Nasdaq Investment Advice Financials FY2018βFY2025
What GCM Grosvenor Inc. does
No business description yet.
- Legal name
- GCM Grosvenor Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0001819796-26-000010
0001819796
Revenue and margins
GCM Grosvenor Inc. had $558M of revenue in fiscal 2025, up 8.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $175M in fiscal 2025, 31.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
GCM Grosvenor Inc. returned $30.7M to shareholders in fiscal 2025, 18% of free cash flow. The diluted share count rose 3.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably GCM Grosvenor Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $96.2M | $85.2M | $44.4M | $89.5M | $242M |
| Debt incl. finance leases | $391M | $388M | $385M | $432M | $428M |
| Net debt / EBITDA | 2.6x | 3.6x | β | 4.5x | 1.4x |
| Debt / equity | β | β | β | β | 15.9x |
| Interest coverage | 5.4x | 3.4x | β0.5x | 3.0x | 5.9x |
| Total assets | $582M | $489M | $505M | $613M | $814M |
| Total liabilities | $637M | $583M | $616M | $703M | $686M |
| Shareholders' equity | β$25.7M | β$19.8M | β$27.6M | β$27.6M | $27.0M |
| Net debt (β = net cash) | $294M | $302M | $340M | $343M | $186M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 7 | 5 / 7 | 5 / 7 | 5 / 7 | 5 / 7 | 5 / 7 |
| Accruals ratio | β | β25.8% | β12.8% | β25.9% | β36.7% | β16.0% | β23.3% | β19.4% |
| Altman Z'' | β | β | β | β | β | β | β | β |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $378M | $416M | $430M | $532M | $447M | $445M | $514M | $558M |
| Operating income | $75.1M | $85.0M | β$43.1M | $109M | $80.3M | β$11.8M | $73.5M | $133M |
| Interest expense | $26.5M | $25.7M | $23.4M | $20.1M | $23.3M | $23.7M | $24.2M | $22.8M |
| Pretax income | $65.1M | $62.3M | β$78.7M | $153M | $89.1M | β$21.5M | $50.2M | $155M |
| Income tax | $1.4M | $2.3M | $4.5M | $11.0M | $9.6M | $7.7M | $13.6M | $12.9M |
| Net income | $0.0M | $0.0M | $4.0M | $21.5M | $19.8M | $12.8M | $18.7M | $45.4M |
| Net income to common | β | β | $4.0M | $21.5M | $19.8M | $12.8M | $18.7M | $45.4M |
| Diluted EPS | $0.00 | $0.00 | β$0.58 | $0.28 | $0.28 | β$0.28 | $0.03 | $0.42 |
| Diluted shares | 0.00B | 0.00B | 0.18B | 0.19B | 0.19B | 0.19B | 0.19B | 0.20B |
| Cash flow | ||||||||
| Cash from operations | $117M | $96.2M | $68.2M | $179M | $217M | $92.1M | $149M | $184M |
| Capital expenditure | $0.9M | $4.0M | $1.3M | $0.6M | $0.8M | $3.8M | $16.7M | $8.5M |
| Free cash flow | $116M | $92.2M | $66.9M | $178M | $216M | $88.3M | $132M | $175M |
| Depreciation and amortization | $11.7M | $10.3M | $9.8M | $4.0M | $3.9M | $2.7M | $3.3M | $4.4M |
| Stock-based compensation | β | $0.0M | $0.0M | $44.2M | $30.7M | $50.7M | $48.2M | $45.6M |
| Share buybacks | β | $0.0M | $0.0M | $0.9M | $26.4M | $4.5M | $0.0M | $30.7M |
| Dividends and buybacks | β | $0.0M | $0.0M | $0.9M | $26.4M | $4.5M | $0.0M | $30.7M |
| Balance sheet | ||||||||
| Cash and short-term investments | $68.1M | $79.9M | $198M | $96.2M | $85.2M | $44.4M | $89.5M | $242M |
| Total debt | β | $449M | $335M | $391M | $388M | $385M | $432M | $428M |
| Property and equipment, net | β | $8.9M | $7.9M | $5.4M | $4.6M | $7.4M | $22.7M | $29.9M |
| Goodwill | β | $29.0M | $29.0M | $29.0M | $29.0M | $29.0M | $29.0M | $29.0M |
| Intangible assets | β | $16.1M | $8.6M | $6.3M | $3.9M | $2.6M | $1.3M | $0.0M |
| Total assets | β | $373M | $632M | $582M | $489M | $505M | $613M | $814M |
| Total liabilities | β | $587M | $599M | $637M | $583M | $616M | $703M | $686M |
| Preferred stock | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β | β | β$29.3M | β$25.7M | β$19.8M | β$27.6M | β$27.6M | $27.0M |
| Margins | ||||||||
| Operating margin | 19.8% | 20.4% | β10.0% | 20.6% | 18.0% | β2.7% | 14.3% | 23.9% |
| EBITDA margin | 22.9% | 22.9% | β7.7% | 21.3% | 18.8% | β2.1% | 14.9% | 24.7% |
| Net margin | 0.0% | 0.0% | 0.9% | 4.0% | 4.4% | 2.9% | 3.6% | 8.1% |
| FCF margin | 30.7% | 22.1% | 15.6% | 33.5% | 48.3% | 19.8% | 25.7% | 31.4% |
| Returns | ||||||||
| Return on capital | β | β | β31.6% | 37.8% | 25.3% | β3.0% | 17.0% | 57.4% |
| Return on assets | β | 0.0% | 0.8% | 3.5% | 3.7% | 2.6% | 3.3% | 6.4% |
| Growth | ||||||||
| Revenue growth | β | 10.0% | 3.3% | 23.6% | β16.0% | β0.3% | 15.5% | 8.5% |
| Net income growth | β | β | β | 430.6% | β7.7% | β35.5% | 46.4% | 142.7% |
| EPS growth | β | β | β | β | 0.0% | β200.0% | β | 1,300.0% |
| FCF growth | β | β20.6% | β27.5% | 166.6% | 21.0% | β59.1% | 49.5% | 32.6% |
| Share count change | β | β | β | 2.6% | β0.3% | β0.6% | 1.7% | 3.5% |
| Financial health | ||||||||
| Net debt / EBITDA | β | 3.9x | β | 2.6x | 3.6x | β | 4.5x | 1.4x |
| Debt / equity | β | β | β | β | β | β | β | 15.9x |
| Interest coverage | 2.8x | 3.3x | β1.8x | 5.4x | 3.4x | β0.5x | 3.0x | 5.9x |
| Capital allocation | ||||||||
| Capex / revenue | 0.2% | 1.0% | 0.3% | 0.1% | 0.2% | 0.8% | 3.3% | 1.5% |
| Stock comp / revenue | β | 0.0% | 0.0% | 8.3% | 6.9% | 11.4% | 9.4% | 8.2% |
| Payouts / FCF | β | 0.0% | 0.0% | 0.5% | 12.2% | 5.1% | 0.0% | 17.5% |
| Quality scores | ||||||||
| Piotroski F-score | β | β | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| Accruals ratio | β | β25.8% | β12.8% | β25.9% | β36.7% | β16.0% | β23.3% | β19.4% |
Source: SEC EDGAR XBRL filings (CIK 0001819796). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.